
Gagandeep Singh Bedi has resigned as managing director, according to a statement released by AstraZeneca Pharma India on Wednesday.
The pharmaceutical company announced that Sanjeev Panchal has been appointed as managing director for a three-year term beginning January 1, 2023.
According to the statement, Panchal began working for AstraZeneca Pharma in February 2003 as a brand associate and advanced through a number of positions in Singapore and the United Kingdom (UK), India, Indonesia, and the Asia Pacific area.
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
The US Federal committee's meeting will conclude on March 16, 2022.
No Record Found